Back to Search Start Over

Huntington’s Disease Clinical Trials Update: September 2024

Authors :
Farag, Mena
Tabrizi, Sarah J
Wild, Edward J
Source :
Journal of Huntington's Disease; November 2024, Vol. 13 Issue: 4 p409-418, 10p
Publication Year :
2024

Abstract

In this edition of the Huntington's Disease Clinical Trials Update, we expand on the ongoing extension study of PTC518 from PTC Therapeutics, including 12-month interim results from the parent study. We also discuss 24-month interim results from uniQure's AMT-130 program and 28-week follow-up results from Wave Life Sciences’ SELECT-HD clinical trial of WVE-003. Additionally, we provide a comprehensive listing of all currently registered and ongoing clinical trials in Huntington's disease.

Details

Language :
English
ISSN :
18796397 and 18796400
Volume :
13
Issue :
4
Database :
Supplemental Index
Journal :
Journal of Huntington's Disease
Publication Type :
Periodical
Accession number :
ejs67916024
Full Text :
https://doi.org/10.1177/18796397241293955